1、肿瘤、炎症性及感染性皮肤病等领域先进药物递送系统研究;
2、新型光动力、光热治疗药物的设计与评价；
3、皮肤疾病领域的小分子创新药和中药新药开发。
1. Advanced drug delivery systems for tumor, inflammatory & infectious skin diseases
2. Design & evaluation of novel photodynamic/photothermal therapeutic agents
3. Development of small-molecule innovative drugs & new TCM agents for skin diseases
上海市皮肤病医院/同济大学附属皮肤病医院副院长，国家药物/医疗器械临床试验机构主任，上海中药外用制剂创新工程技术研究中心主任、上海市皮肤新药转化平台、皮肤科创新药开放性成果产业化LAB负责人，同济大学医学院皮肤病研究所副所长。担任中国麻风防治协会药物治疗学分会主任委员、世界中医药学联合会经皮给药专委会副会长、世界中医药学会联合会标准审定专家等学术职务。
Vice President, Shanghai Skin Disease Hospital / Dermatology Hospital Affiliated to Tongji University
Director, National Drug/Medical Device Clinical Trial Institution
Director, Shanghai Engineering Research Center for External Chinese Medicine
Leader, Shanghai Skin New Drug Transformation Platform & Dermatological Innovative Drug Open Achievement Industrialization LAB
Deputy Director, Institute of Dermatology, Tongji University School of Medicine
Chairman, Pharmacotherapy Branch, China Leprosy Association
Vice President, Transdermal Drug Delivery Professional Committee, World Federation of Chinese Medicine Societies (WFCMS)
Standard Review Expert, World Federation of Chinese Medicine Societies (WFCMS)
2021、2023、2024、2025年4次入选全球2%顶尖科学家。入选上海市东方英才计划（拔尖项目），获第24届中国专利优秀奖、第五届上海知识产权创新奖、“春昇杯”医学创新人才大赛二等奖和上海市高价值专利运营大赛百强。
带领团队致力于皮肤药学研究领域创新发展，聚焦肿瘤、炎症性皮肤病、皮肤感染等领域，在针对上述疾病的新型递药系统、药物新靶点发现、小分子药物和中药新药开发等方向取得了一系列成果。
近5年，团队成员承担国家自然科学基金13项、省部级课题15项，总科研经费2000余万元；发表SCI学术论文百余篇，包括CellResearch，Actapharmaceutica Sinica B，Chemical Engineering Journal，Journalof Controlled Release，Journal of Advanced Research，Journalof Medicinal Chemistry等知名期刊，总影响因子超500分；申请国家发明专利20余项、PCT专利7项，授权发明专利15项,主编、副主编著作4部。
Selected as Top 2% Scientists Worldwide (2021, 2023, 2024, 2025) . Admitted to Shanghai Oriental Talents Program (Top-Tier Project)
Awards: 24th China Patent Excellence Award, 5th Shanghai Intellectual Property Innovation Award, 2nd Prize of "Chunsheng Cup" Medical Innovation Talent Competition, Top 100 of Shanghai High-Value Patent Operation Competition
Leads a team focusing on dermatopharmacy innovation (oncology, inflammatory skin diseases, skin infections), achieving breakthroughs in novel drug delivery systems, new drug targets, small-molecule drugs & new TCM development.
Past 5 years: Undertaken 13 National Natural Science Foundation projects + 15 provincial/ministerial projects (total funding: >¥20 million); published 100+ SCI papers (Cell Research, Acta Pharmaceutica Sinica B, etc., total IF >500); 20+ national invention patent applications, 7 PCT patents, 15 granted patents; Chief/Associate Editor of 4 monographs.
